← Back
Data updated: Mar 10, 2026
ESI LEDERLE
Pharmaceuticals
ESI LEDERLE is a pharmaceutical company with 2 FDA-approved products.
-
Since
2
Drugs
-
Trials
17
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
POTASSIUM CHLORIDE 2025-12-22
PROPOFOL 2025-12-02
POTASSIUM CHLORIDE 2025-11-20
POTASSIUM CHLORIDE 2025-10-27
Labeling
PROPOFOL 2025-09-19
Labeling
POTASSIUM CHLORIDE 2025-09-10
PROPOFOL 2025-08-12
Labeling
POTASSIUM CHLORIDE 2025-07-22
POTASSIUM CHLORIDE 2025-07-11
POTASSIUM CHLORIDE 2025-04-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 2